rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    AZTA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Azenta to Participate in the 9th Annual Evercore Healthcare Conference
      Nov 17Yahoo FinanceAZTAEVR
      Stocks making big moves this week: Gevo, AAON, Lincoln Educational, Azenta, and Coinbase

      Detailed price information for Coinbase Global Cl A (COIN-Q) from The Globe and Mail including charting and trades.

      Nov 13The Globe and MailAZTACOINGEVOLINC
      Azenta dips 7% as investors book profits after earnings surge

      Azenta shares fall 7.4% after its fiscal Q4 call; revenue rises 5% to $167 million, while Multiomics organic sales decline 1%.

      Nov 12Seeking AlphaAZTA
      Why Azenta Stock Crushed it on Wednesday | The Motley Fool

      Its final earnings report for fiscal 2026 was impressive.

      Nov 12The Motley FoolAZTA
      Azenta (AZTA) Following Earnings And Deals Has Its Valuation Story Changed
      Nov 12Yahoo FinanceAZTA
      Azenta Inc (AZTA) (Q4 2026) Earnings Call Highlights: Revenue Tops Guidance as Gene Synthesis ...
      Nov 11Yahoo FinanceAZTA
      What Azenta (AZTA) Said on Its Q4 Earnings Call
      Nov 11Yahoo FinanceAZTA
      Azenta Q4 2026 slides: 11.6% EBITDA margin, 3-5% growth ahead
      Nov 11Investing.comAZTA
      Azenta, Inc. Q4 2026 Earnings Call Summary
      Nov 11Yahoo FinanceAZTA
      Azenta earnings beat by $0.16, revenue topped estimates
      Nov 11Investing.comAZTA
      Azenta stock soars over 8% after topping Q4 estimates, guiding above consensus
      Nov 10Investing.comAZTA
      Azenta (NASDAQ:AZTA) reports upbeat Q3 CY2026, stock jumps 10.3%
      Nov 10Yahoo FinanceAZTA
      Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026.
      Nov 10Yahoo FinanceAZTA
      Azenta set to report earnings amid margin pressure concerns
      Nov 10Investing.comAZTA
      Azenta: A Sample Custody Annuity Priced Like A Broken Equipment Vendor (NASDAQ:AZTA)

      Azenta looks undervalued as recurring revenue tops 50% and cash nears 30% of market cap. Click for more on AZTA stock.

      Nov 3Seeking AlphaAZTA
      Azenta Stock Outlook After DNA Technology Deal
      Nov 1Yahoo FinanceAZTA
      Azenta Expands Genewiz Business With Licensing Deal, Acquisition
      Oct 30Yahoo FinanceAZTA
      Azenta licenses Elegen tech, acquires SynPlexity for GENEWIZ unit
      Oct 30Investing.comAZTA
      Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities
      Oct 30Yahoo FinanceAZTA
      Azenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and Webcast
      Oct 28Yahoo FinanceAZTA
      Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know
      Oct 19Yahoo FinanceAZTAMRNAPGNYAGL
      Azenta (AZTA) Could Be 14% Below Fair Value Following Margin Expansion Narrative
      Oct 18Yahoo FinanceAZTA
      Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
      Oct 16Yahoo FinanceAZTAMYGNRGEN
      Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
      Oct 10MorningstarAZTA
      Azenta stock hits 52-week high at 41.84 USD
      Oct 2Investing.comAZTA
      Azenta formalizes interim CEO pay and retention grants

      Detailed price information for Azenta Inc (AZTA-Q) from The Globe and Mail including charting and trades.

      Sep 18The Globe and MailAZTA
      Azenta sets compensation terms for interim CEO and grants executive retention awards
      Sep 17Investing.comAZTA
      Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA)

      As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Azenta (NASDAQ:AZTA) and its peers.

      Sep 14Yahoo FinanceAZTA
      Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA)
      Sep 13BarchartAZTA
      Azenta Completes B Medical Divestiture With Loan Repayment

      Detailed price information for Azenta Inc (AZTA-Q) from The Globe and Mail including charting and trades.

      Sep 5The Globe and MailAZTA
      Azenta completes B Medical sale as vendor loan repaid (AZTA)
      Sep 4Seeking AlphaAZTA
      Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
      Sep 4Yahoo FinanceAZTA
      Azenta Receives Early Repayment of $35 Million Vendor Loan

      Azenta (AZTA) said Friday it received full repayment, ahead of maturity, of a $35 million secured ve

      Sep 4Yahoo FinanceAZTA
      Stocks making big moves yesterday: Funko, Hims & Hers Health, Azenta, Strategy, and RUM Group

      Check out the companies making headlines yesterday:

      Aug 25Yahoo FinanceAZTAFNKOHIMS
      Azenta CEO Resigns as Interim Leader Reassures Outlook

      Detailed price information for Azenta Inc (AZTA-Q) from The Globe and Mail including charting and trades.

      Aug 25The Globe and MailAZTA
      Azenta tumbles 12% after CEO transition (AZTA:NASDAQ)
      Aug 24Seeking AlphaAZTA
      Why Azenta (AZTA) Stock Is Down Today

      Shares of life sciences company Azenta (NASDAQ:AZTA) fell 9.1% in the afternoon session after the company announced, in a regulatory filing, that President and CEO John Marotta resigned from his executive roles and board seat, with current director Dr. Martin Madaus appointed as interim President and CEO.

      Aug 24Yahoo FinanceAZTA
      Why is Azenta stock sliding today?
      Aug 24Investing.comAZTA
      Azenta appoints interim CEO as John Marotta resigns
      Aug 24Investing.comAZTA
      AZENTA ANNOUNCES LEADERSHIP TRANSITION

      Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has been appointed interim President and CEO, and that John Marotta has resigned as an executive officer and director of the Company.

      Aug 24Yahoo FinanceAZTA
      Azenta Names Board Member Martin Madaus as Interim CEO
      Aug 24Yahoo FinanceAZTA

      This is the newest page. Registered accounts read further back.